Expansion momentum ACT LAB is rapidly expanding its US testing footprint, with recent NJ openings and acquisition of Sriven Labs, presenting a sales opportunity to align with new facilities and regulatory-compliant testing needs across multiple states.

Regulatory leadership Position ACT LAB as a premier partner for cannabis and hemp testing by leveraging its pharmaceutical-grade quality systems, vast standardization, and multi-state network to help licensed cultivators and processors meet evolving compliance and supply chain requirements.

Integrated platform Highlight the value of a consolidated, private-ownership testing network across states, offering consistent service delivery, streamlined reporting, and scalable testing capacity that supports grower consolidation and cross-border operations.

Tech-enabled efficiency Leverage ACT LAB’s tech stack (AWS, HubSpot Analytics, QuickBooks, WordPress, etc.) to propose seamless onboarding, automated reporting, and data-driven QA that reduces time-to-result and improves audit readiness for customers.

Financial scale With mid-market revenue and an established client base in cannabis and hemp, target growth-stage cultivators and processors seeking reliable testing partners to support expansion, product launches, and increased regulatory scrutiny.